{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:35:56Z","timestamp":1773941756075,"version":"3.50.1"},"reference-count":20,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,11]]},"DOI":"10.1182\/bloodadvances.2022008442","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T17:57:35Z","timestamp":1670003855000},"page":"1103-1107","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Wnt inhibitors reduce the unfolded protein response and enhance bortezomib-induced cell death in multiple myeloma"],"prefix":"10.1182","volume":"7","author":[{"given":"Ingrid","family":"Spaan","sequence":"first","affiliation":[{"name":"1Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4120-7898","authenticated-orcid":false,"given":"Niels","family":"van Nieuwenhuijzen","sequence":"additional","affiliation":[{"name":"1Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"},{"name":"2Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kimman","sequence":"additional","affiliation":[{"name":"1Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedeke","family":"Rockx-Brouwer","sequence":"additional","affiliation":[{"name":"1Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9419-6988","authenticated-orcid":false,"given":"Ralph G.","family":"Tieland","sequence":"additional","affiliation":[{"name":"1Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6885-5361","authenticated-orcid":false,"given":"Madelon M.","family":"Maurice","sequence":"additional","affiliation":[{"name":"3Oncode Institute, Utrecht, The Netherlands"},{"name":"4Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3139-8379","authenticated-orcid":false,"given":"Monique C.","family":"Minnema","sequence":"additional","affiliation":[{"name":"2Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4352-4598","authenticated-orcid":false,"given":"Reinier A.","family":"Raymakers","sequence":"additional","affiliation":[{"name":"2Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9011-3820","authenticated-orcid":false,"given":"Victor","family":"Peperzak","sequence":"additional","affiliation":[{"name":"1Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"issue":"6","key":"2023090715335440500_bib1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"issue":"11","key":"2023090715335440500_bib2","first-page":"1757","article-title":"Wnt signaling in leukemias and myeloma: T-cell factors are in control","volume":"9","author":"Tiemessen","year":"2013","journal-title":""},{"issue":"1","key":"2023090715335440500_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-018-0615-3","article-title":"Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential","volume":"11","author":"Spaan","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2023090715335440500_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41375-019-0404-1","article-title":"Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options","volume":"33","author":"van Andel","year":"2019","journal-title":"Leukemia"},{"issue":"16","key":"2023090715335440500_bib5","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1073\/pnas.0305855101","article-title":"Illegitimate WNT signaling promotes proliferation of multiple myeloma cells","volume":"101","author":"Derksen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2023090715335440500_bib6","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood-2008-12-194290","article-title":"Aurora kinase A is a target of Wnt\/beta-catenin involved in multiple myeloma disease progression","volume":"114","author":"Dutta-Simmons","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2023090715335440500_bib7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/sj.onc.1206239","article-title":"Wnt signaling in B-cell neoplasia","volume":"22","author":"Qiang","year":"2003","journal-title":"Oncogene"},{"issue":"7264","key":"2023090715335440500_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"issue":"2","key":"2023090715335440500_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/0008-5472.CAN-12-2258","article-title":"Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer","volume":"73","author":"Proffitt","year":"2013","journal-title":"Cancer Res"},{"issue":"4","key":"2023090715335440500_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2021.279517","article-title":"Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition","volume":"107","author":"Cuenca","year":"2022","journal-title":"Haematologica"},{"issue":"9","key":"2023090715335440500_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41590-020-0708-3","article-title":"XBP-1 and the unfolded protein response (UPR)","volume":"21","author":"Glimcher","year":"2020","journal-title":"Nat Immunol"},{"key":"2023090715335440500_bib12","doi-asserted-by":"crossref","first-page":"e27187","DOI":"10.7554\/eLife.27187","article-title":"The Sec61 translocon limits IRE1\u03b1 signaling during the unfolded protein response","volume":"6","author":"Sundaram","year":"2017","journal-title":"Elife"},{"issue":"4","key":"2023090715335440500_bib13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jaci.2017.06.042","article-title":"Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1)","volume":"141","author":"Schubert","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"2023090715335440500_bib14","doi-asserted-by":"crossref","first-page":"21626","DOI":"10.1038\/s41598-020-78293-3","article-title":"MZB1 enables efficient interferon \u03b1 secretion in stimulated plasmacytoid dendritic cells","volume":"10","author":"Kapoor","year":"2020","journal-title":"Sci Rep"},{"key":"2023090715335440500_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1756-8722-3-40","article-title":"The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1","volume":"3","author":"Usmani","year":"2010","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"2023090715335440500_bib16","first-page":"1","article-title":"Amplified RLR signaling activation through an interferon-stimulated gene-endoplasmic reticulum stress-mitochondrial calcium uniporter protein loop","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"2023090715335440500_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13046-020-01646-3","article-title":"IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress","volume":"39","author":"Liu","year":"2020","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"6","key":"2023090715335440500_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/1535-7163.MCT-12-0782","article-title":"Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma","volume":"12","author":"Vincenz","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"2023090715335440500_bib19","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1535-7163.MCT-16-0624","article-title":"\u03b2-catenin inhibitor BC2059 is efficacious as monotherapy or in combination with proteasome inhibitor bortezomib in multiple myeloma","volume":"16","author":"Savvidou","year":"2017","journal-title":"Mol Cancer Therapeut"},{"issue":"4","key":"2023090715335440500_bib20","first-page":"5871","article-title":"Anthelmintic pyrvinium pamoate blocks Wnt\/\u03b2-catenin and induces apoptosis in multiple myeloma cells","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol Lett"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/7\/1103\/2076730\/blooda_adv-2022-008442-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/7\/1103\/2076730\/blooda_adv-2022-008442-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T15:34:46Z","timestamp":1694100886000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/7\/1103\/493386\/Wnt-inhibitors-reduce-the-unfolded-protein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,4,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008442","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]}}}